Targeting Protein Kinases for Cancer Therapy

Awards:   Winner of PROSE (Biomedicine/Neuroscience) 2010
Author:   David J. Matthews ,  Mary E. Gerritsen
Publisher:   John Wiley & Sons Inc
ISBN:  

9780470229651


Pages:   720
Publication Date:   12 March 2010
Format:   Hardback
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Our Price $298.95 Quantity:  
Add to Cart

Share |

Targeting Protein Kinases for Cancer Therapy


Add your own review!

Awards

  • Winner of PROSE (Biomedicine/Neuroscience) 2010

Overview

Full Product Details

Author:   David J. Matthews ,  Mary E. Gerritsen
Publisher:   John Wiley & Sons Inc
Imprint:   John Wiley & Sons Inc
Dimensions:   Width: 5.80cm , Height: 3.60cm , Length: 10.90cm
Weight:   1.043kg
ISBN:  

9780470229651


ISBN 10:   0470229659
Pages:   720
Publication Date:   12 March 2010
Audience:   College/higher education ,  Postgraduate, Research & Scholarly
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Reviews

The comprehensive coverage makes the book highly recommendable for beginners and expert researchers in oncology and should be present on their shelves. ( ChemMedChem , November 2010)


The comprehensive coverage makes the book highly recommendable for beginners and expert researchers in oncology and should be present on their shelves. (ChemMedChem, November 2010)


Author Information

DAVID J. MATTHEWS is Executive Director of Oncology Discovery at Exelixis, where he is responsible for cancer drug discovery. For more than fifteen years, Dr. Matthews has been involved in drug discovery projects in industry, with particular focus on small molecule inhibitors. He has twenty scientific publications and multiple patents to his credit. MARY E. GERRITSEN is Vice President of Molecular and Cellular Pharmacology at Exelixis, where she is in charge of cell-based screening in preclinical research and of biomarker studies for clinical development compounds in Phase I and II studies. Her prior industry experience includes positions at Genentech, Bayer and Millennium Pharmaceuticals. She has authored more than one hundred peer-reviewed articles and twenty-six book chapters and is an inventor on forty-two issued patents.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List